医药与健康护理：财政部新闻发布会解读-增长确定，期待后续财政空间

Investment Rating - The report indicates a positive outlook for the pharmaceutical industry, highlighting its growth certainty and potential for investment opportunities [5][6]. Core Insights - The Ministry of Finance announced a series of targeted incremental policy measures to support economic growth, with a focus on the pharmaceutical sector [5]. - The per capita public health service funding will increase to 94 yuan per year, and the basic medical insurance subsidy for urban and rural residents will rise to 670 yuan per year, indicating stable and sustainable financial support for the pharmaceutical industry [5][6]. - The expected increase in urban and rural residents' medical insurance funding will bring approximately 35.9 billion yuan in additional funds, with total medical insurance income projected to exceed 1.1 trillion yuan in 2024, reflecting a year-on-year growth of 3.4% [5][6]. Summary by Sections Policy Support - The report emphasizes the government's commitment to enhancing public health services, particularly for the elderly and chronic disease patients, through increased fiscal spending [6]. - Specific policies under consideration include supporting local governments in managing debt risks, issuing special government bonds to bolster bank capital, and enhancing support for key demographic groups [6]. Financial Projections - The report forecasts that the basic medical insurance income will reach approximately 3.5 trillion yuan in 2024, with an increase of 113.8 billion yuan compared to 2023 [5][6]. - The expected fiscal investment in basic public health services for 2024 is projected to be around 131.6 billion yuan, marking an increase of 6.1 billion yuan from 2023 [5][6].